Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BerGenBio ASA ( (BRRGF) ) just unveiled an update.
Oncoinvent ASA has completed a fully underwritten rights issue, resulting in the allocation of 260,000,000 new shares to various primary insiders and their close associates. This significant capital raise is contingent upon approval at an extraordinary general meeting and is subject to regulatory disclosure requirements.
The most recent analyst rating on (BRRGF) stock is a Buy with a NOK38.00 price target. To see the full list of analyst forecasts on BerGenBio ASA stock, see the BRRGF Stock Forecast page.
More about BerGenBio ASA
Average Trading Volume: 443,119
Current Market Cap: NOK208.3M
For an in-depth examination of BRRGF stock, go to TipRanks’ Overview page.